Skip to main content
. 2014 Jan 9;3(1):1–24. doi: 10.3390/jcm3010001

Figure 2.

Figure 2

Forest plot of comparison: Overall risk of SREs (excluding hypercalcemia) from breast cancer bone metastases: bisphosphonate versus control. Reproduced with permission from the ©Cochrane Collaboration [25].